Why South Africa urgently needs to support the development of pregnancy exposure registries

S Afr Med J. 2019 Apr 29;109(5):294-295. doi: 10.7196/SAMJ.2019.v109i5.14008.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Retroviral Agents / adverse effects*
  • Female
  • HIV Infections / drug therapy*
  • Humans
  • Incidence
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy*
  • Pregnancy Outcome
  • Prenatal Exposure Delayed Effects / epidemiology*
  • Prenatal Exposure Delayed Effects / etiology
  • Registries*
  • South Africa / epidemiology
  • Surveys and Questionnaires

Substances

  • Anti-Retroviral Agents